tiprankstipranks
Trending News
More News >
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market
Advertisement

VistaGen Therapeutics (VTGN) Financial Statements

Compare
876 Followers

VistaGen Therapeutics Financial Overview

VistaGen Therapeutics's market cap is currently $119.35M. The company's EPS TTM is $-0.47; its P/E ratio is ―; VistaGen Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Currency in USD

VistaGen Therapeutics Earnings and Revenue History

VistaGen Therapeutics Debt to Assets

VistaGen Therapeutics Cash Flow

VistaGen Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis